Intravenous anti–IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis

Lebrikizumab Treatment in Adults with Asthma

Jonathan Corren, Robert F. Lemanske, Nicola A. Hanania et al. · New England Journal of Medicine · 2011 · 1.5K citations

Pharmacy, Immunology, Pharmacology +12

An etiological role for aeroallergens and eosinophils in experimental esophagitis

Anil Mishra, Simon P. Hogan, Eric B. Brandt et al. · Journal of Clinical Investigation · 2001 · 631 citations · Full text

Life Sciences, Immunology, Pathobiology +17

Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients

Guiquan Jia, Richard W. Erickson, David F. Choy et al. · Journal of Allergy and Clinical Immunology · 2012 · 611 citations · Full text

Veterinary Medicine, Immunology, Pathobiology +10

Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial

Alex Straumann, Sébastien Conus, Pascale Grzonka et al. · Gut · 2009 · 589 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +16

Reslizumab in children and adolescents with eosinophilic esophagitis: Results of a double-blind, randomized, placebo-controlled trial

Jonathan M. Spergel, Marc E. Rothenberg, Margaret H. Collins et al. · Journal of Allergy and Clinical Immunology · 2011 · 551 citations

Medicine, Pediatrics, Pharmacotherapy +11